Kathryn A. Hall’s Celgene Corp CELG Stock Holding History

Kathryn A. Hall’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-4,000	Closed	-$461K	–	72
2015 Q1	$461K	Hold	4,000	–	–	0.16%	20
2014 Q4	$447K	Buy	+4,000	New	+$422K	0.12%	22

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kathryn A. Hall's CELG Position: Q2 2015 in Review

Kathryn A. Hall sold out of Celgene Corp (CELG) in Q2 2015, closing a stake of 4,000 shares — an estimated $461K sold.

Kathryn A. Hall first reported a position in CELG in Q4 2014 and held it in 2 quarters. The position peaked at $461K in Q1 2015. 1,201 funds tracked by Wall St. Rank hold CELG as of Q2 2015.

Kathryn A. Hall reported no remaining Celgene Corp position as of Q2 2015 after selling out during the quarter.
Kathryn A. Hall sold 4,000 Celgene Corp shares in Q2 2015, an estimated $461K.
Kathryn A. Hall first reported a position in Celgene Corp in Q4 2014 and held it in 2 quarters.
Kathryn A. Hall's Celgene Corp position peaked at $461K in Q1 2015.
1,201 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2015.

Based on Kathryn A. Hall's 13F filing for Q2 2015, filed 13 Aug 2015.